C9orf72 isoforms in Amyotrophic Lateral Sclerosis and Frontotemporal Lobar Degeneration

Shangxi Xiao1, Laura MacNair2, Jesse McLean1

  • 1Tanz Centre for Research in Neurodegenerative Diseases, University of Toronto, Canada.

Brain Research
|May 3, 2016
PubMed

Insights

The C9orf72 gene's hexanucleotide repeat expansion causes ALS and FTD. This review explores C9orf72's normal function and how its altered expression contributes to neurodegenerative disease pathogenesis.

Area of Science:

  • Neuroscience
  • Genetics
  • Molecular Biology

Background:

  • The C9orf72 gene hexanucleotide repeat expansion is the leading genetic cause of amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD).
  • Proposed toxic mechanisms include RNA foci, dipeptide repeat proteins, and C9orf72 haploinsufficiency.
  • While gain-of-function mechanisms are studied, the normal function of C9orf72 and consequences of its perturbation remain less understood.

Purpose of the Study:

  • To review current knowledge of C9orf72 at transcript and protein levels.
  • To explore how altered C9orf72 expression contributes to neurodegenerative disease pathogenesis.
  • To highlight the knowledge gaps concerning C9orf72's normal function.

Main Methods:

  • Literature review of studies on C9orf72.
  • Analysis of C9orf72 transcript and protein expression.
  • Discussion of proposed toxic gain-of-function and loss-of-function mechanisms.
  • Integration of findings within the context of RNA metabolism in disease.

Main Results:

  • C9orf72's role in disease is linked to repeat expansions, RNA foci, dipeptide proteins, and haploinsufficiency.
  • Significant knowledge gaps exist regarding C9orf72's normal cellular functions.
  • Understanding C9orf72's physiological roles is crucial for elucidating disease mechanisms.

Conclusions:

  • Further research into C9orf72's normal function is essential.
  • Elucidating C9orf72's cellular roles will advance understanding of ALS and FTLD.
  • This review synthesizes current knowledge on C9orf72 in neurodegeneration and RNA metabolism.

Related Concept Videos

Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining,...
12.8K
Amyloid Fibrils03:03

Amyloid Fibrils

6.9K
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.7K
RNA Splicing01:32

RNA Splicing

Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
61.2K